257 related articles for article (PubMed ID: 18410971)
1. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
Shiraishi M; Ichiyama T; Matsushige T; Iwaki T; Iyoda K; Fukuda K; Makata H; Matsubara T; Furukawa S
J Neuroimmunol; 2008 May; 196(1-2):147-52. PubMed ID: 18410971
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.
Shimizu M; Kuroda M; Sakashita N; Konishi M; Kaneda H; Igarashi N; Yamahana J; Taneichi H; Kanegane H; Ito M; Saito S; Ohta K; Taniguchi T; Furuichi K; Wada T; Nakagawa M; Yokoyama H; Yachie A
Cytokine; 2012 Dec; 60(3):694-700. PubMed ID: 22929411
[TBL] [Abstract][Full Text] [Related]
3. Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection.
Ichiyama T; Ito Y; Kubota M; Yamazaki T; Nakamura K; Furukawa S
Brain Dev; 2009 Nov; 31(10):731-8. PubMed ID: 19114298
[TBL] [Abstract][Full Text] [Related]
4. Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures.
Ichiyama T; Suenaga N; Kajimoto M; Tohyama J; Isumi H; Kubota M; Mori M; Furukawa S
Brain Dev; 2008 Jan; 30(1):47-52. PubMed ID: 17597322
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy.
Ichiyama T; Morishima T; Isumi H; Matsufuji H; Matsubara T; Furukawa S
Cytokine; 2004 Jul; 27(1):31-7. PubMed ID: 15207249
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia.
Sunagawa S; Ichiyama T; Honda R; Fukunaga S; Maeba S; Furukawa S
Brain Dev; 2009 Sep; 31(8):588-93. PubMed ID: 18849127
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic and cytokine balance abnormalities in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass.
Paśnik J; Moll J; Cywińska-Bernas A; Moll J; Sysa A; Zeman K
Kardiol Pol; 2007 Oct; 65(10):1208-14; discussion 1215. PubMed ID: 17979049
[TBL] [Abstract][Full Text] [Related]
8. Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Suenaga N; Ichiyama T; Kubota M; Isumi H; Tohyama J; Furukawa S
J Neurol Sci; 2008 Mar; 266(1-2):126-30. PubMed ID: 17928006
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis.
Ichiyama T; Kajimoto M; Suenaga N; Maeba S; Matsubara T; Furukawa S
J Neuroimmunol; 2006 Mar; 172(1-2):182-6. PubMed ID: 16321449
[TBL] [Abstract][Full Text] [Related]
10. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia.
El Messal M; Beaudeux JL; Drissi A; Giral P; Chater R; Bruckert E; Adlouni A; Chapman MJ
Clin Chim Acta; 2006 Apr; 366(1-2):185-9. PubMed ID: 16280123
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis.
Ichiyama T; Siba P; Suarkia D; Takasu T; Miki K; Kira R; Kusuhara K; Hara T; Toyama J; Furukawa S
J Neurol Sci; 2007 Jan; 252(1):45-8. PubMed ID: 17118404
[TBL] [Abstract][Full Text] [Related]
13. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea.
Ichiyama T; Siba P; Suarkia D; Reeder J; Takasu T; Miki K; Maeba S; Furukawa S
Cytokine; 2006 Jan; 33(1):17-20. PubMed ID: 16413199
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.
Ichiyama T; Morishima T; Kajimoto M; Matsushige T; Matsubara T; Furukawa S
Pediatr Infect Dis J; 2007 Jun; 26(6):542-4. PubMed ID: 17529876
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues.
Westerholt S; Hartung T; Tollens M; Güstrau A; Oberhoffer M; Karch H; Klare B; Pfeffer K; Emmrich P; Oberhoffer R
Cytokine; 2000 Jun; 12(6):822-7. PubMed ID: 10843773
[TBL] [Abstract][Full Text] [Related]
17. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Anand SP; Selvaraj P
Clin Immunol; 2009 Oct; 133(1):126-31. PubMed ID: 19615945
[TBL] [Abstract][Full Text] [Related]
19. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
